Biosensing Instrument Inc.
- UEI
- RCL7B2TBY9H9
- CAGE
- 577M3
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- biosensingusa.com
- Founded
- 2004
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Purchase Order VA25014P3155 | Veterans Integrated Service Network 10 (VHA) | $92,725 | |
| Surface plasmon resonance system | Southeast Area (FRIID) | $40,232 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Biosensing Instrument Inc. is a for-profit corporate entity based in Tempe, Arizona, specializing in the development of advanced biomedical research technologies. Registered in SAM.gov since 2008, the company focuses on creating innovative instrumentation and detection systems for molecular interaction analysis, with a particular emphasis on membrane protein research and drug discovery technologies. As a manufacturer of scientific goods, Biosensing Instrument Inc. develops cutting-edge optical detection and imaging systems that enable high-throughput, label-free quantification of molecular binding kinetics and cellular interactions.
The company has secured multiple federal grants from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program, consistently developing advanced technological platforms for scientific research. These grants have supported the development of several breakthrough technologies, including the Spotting-Free Nano-Oscillator Array (SFNOA), Plasmonic Scattering Microscopy (PSM), Critical Angle Reflection Imaging (CARI), and a Charge-Sensitive Optical Detection (CSOD) system. Each project aims to advance molecular interaction analysis, particularly for membrane proteins and small molecule interactions, with potential applications in drug discovery, biomarker identification, and disease diagnosis. The company collaborates closely with Arizona State University researchers and potential customers in biomedical research and pharmaceutical industries to validate and commercialize these innovative technologies, focusing on creating high-throughput, sensitive detection methods that preserve native cellular environments and provide more accurate research insights.
Quick answers
Is Biosensing Instrument Inc. registered in SAM.gov?
Biosensing Instrument Inc.'s SAM.gov registration expired on September 29, 2026.
What is Biosensing Instrument Inc.'s most recent federal award?
Biosensing Instrument Inc.'s most recent federal grant award is Spotting-free nano-oscillator array for quantification of virion displayed membrane protein binding kinetics (R42GM157918), from National Institute of General Medical Sciences (NIH), on April 2, 2025.
On GovTribe
See Biosensing Instrument Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors